166 related articles for article (PubMed ID: 10728173)
1. Venlafaxine versus fluoxetine in the treatment of atypical anorectic outpatients: a preliminary study.
Ricca V; Mannucci E; Paionni A; Di Bernardo M; Cellini M; Cabras PL; Rotella CM
Eat Weight Disord; 1999 Mar; 4(1):10-4. PubMed ID: 10728173
[TBL] [Abstract][Full Text] [Related]
2. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group.
Clerc GE; Ruimy P; Verdeau-Pallès J
Int Clin Psychopharmacol; 1994 Sep; 9(3):139-43. PubMed ID: 7814822
[TBL] [Abstract][Full Text] [Related]
3. A randomized, open-label comparison of venlafaxine and fluoxetine in depressed outpatients.
Diaz-Martinez A; Benassinni O; Ontiveros A; Gonzalez S; Salin R; Basquedano G; Martinez RA
Clin Ther; 1998; 20(3):467-76. PubMed ID: 9663362
[TBL] [Abstract][Full Text] [Related]
4. Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety.
De Nayer A; Geerts S; Ruelens L; Schittecatte M; De Bleeker E; Van Eeckhoutte I; Evrard JL; Linkowski P; Fossion P; Leyman S; Mignon A
Int J Neuropsychopharmacol; 2002 Jun; 5(2):115-20. PubMed ID: 12135535
[TBL] [Abstract][Full Text] [Related]
5. Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.
Asarnow JR; Emslie G; Clarke G; Wagner KD; Spirito A; Vitiello B; Iyengar S; Shamseddeen W; Ritz L; Birmaher B; Ryan N; Kennard B; Mayes T; DeBar L; McCracken J; Strober M; Suddath R; Leonard H; Porta G; Keller M; Brent D
J Am Acad Child Adolesc Psychiatry; 2009 Mar; 48(3):330-339. PubMed ID: 19182688
[TBL] [Abstract][Full Text] [Related]
6. Venlafaxine-fluoxetine interaction.
Benazzi F
J Clin Psychopharmacol; 1999 Feb; 19(1):96-8. PubMed ID: 9934950
[No Abstract] [Full Text] [Related]
7. Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia.
Tzanakaki M; Guazzelli M; Nimatoudis I; Zissis NP; Smeraldi E; Rizzo F
Int Clin Psychopharmacol; 2000 Jan; 15(1):29-34. PubMed ID: 10836283
[TBL] [Abstract][Full Text] [Related]
8. A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients.
Dierick M; Ravizza L; Realini R; Martin A
Prog Neuropsychopharmacol Biol Psychiatry; 1996 Jan; 20(1):57-71. PubMed ID: 8861177
[TBL] [Abstract][Full Text] [Related]
9. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.
Silverstone PH; Ravindran A
J Clin Psychiatry; 1999 Jan; 60(1):22-8. PubMed ID: 10074873
[TBL] [Abstract][Full Text] [Related]
10. Treatment of depression and anxiety in infertile women: cognitive behavioral therapy versus fluoxetine.
Faramarzi M; Alipor A; Esmaelzadeh S; Kheirkhah F; Poladi K; Pash H
J Affect Disord; 2008 May; 108(1-2):159-64. PubMed ID: 17936366
[TBL] [Abstract][Full Text] [Related]
11. Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo.
Shelton C; Entsuah R; Padmanabhan SK; Vinall PE
Int Clin Psychopharmacol; 2005 Jul; 20(4):233-8. PubMed ID: 15933485
[TBL] [Abstract][Full Text] [Related]
12. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.
Keller MB; Trivedi MH; Thase ME; Shelton RC; Kornstein SG; Nemeroff CB; Friedman ES; Gelenberg AJ; Kocsis JH; Dunner DL; Dunlop BW; Hirschfeld RM; Rothschild AJ; Ferguson JM; Schatzberg AF; Zajecka JM; Pedersen R; Yan B; Ahmed S; Schmidt M; Ninan PT
Biol Psychiatry; 2007 Dec; 62(12):1371-9. PubMed ID: 17825800
[TBL] [Abstract][Full Text] [Related]
13. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
Trivedi MH; Thase ME; Osuntokun O; Henley DB; Case M; Watson SB; Campbell GM; Corya SA
J Clin Psychiatry; 2009 Mar; 70(3):387-96. PubMed ID: 19284928
[TBL] [Abstract][Full Text] [Related]
14. Severe anticholinergic side effects with venlafaxine-fluoxetine combination.
Benazzi F
Can J Psychiatry; 1997 Nov; 42(9):980-1. PubMed ID: 9429070
[No Abstract] [Full Text] [Related]
15. Global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine.
Entsuah R; Gorman JM
J Psychiatr Res; 2002; 36(3):111-8. PubMed ID: 11886688
[TBL] [Abstract][Full Text] [Related]
16. Double-blind comparison of venlafaxine and amitriptyline in outpatients with major depression with or without melancholia.
Gentil V; Kerr-Correa F; Moreno R; D'Arrigo Busnello E; De Campos JA; Juruena MF; Lafer B; Moreno DH; De Cassia Rodrigues RL; Tiosso A; Benedictis E
J Psychopharmacol; 2000 Mar; 14(1):61-6. PubMed ID: 10757255
[TBL] [Abstract][Full Text] [Related]
17. Sexual functioning in patients with recurrent major depressive disorder enrolled in the PREVENT study.
Gelenberg AJ; Dunner DL; Rothschild AJ; Pedersen R; Dorries KM; Ninan PT
J Nerv Ment Dis; 2013 Apr; 201(4):266-73. PubMed ID: 23538970
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia.
Ballús C; Quiros G; De Flores T; de la Torre J; Palao D; Rojo L; Gutiérrez M; Casais L; Riesgo Y
Int Clin Psychopharmacol; 2000 Jan; 15(1):43-8. PubMed ID: 10836286
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression.
Rudolph RL; Feiger AD
J Affect Disord; 1999 Dec; 56(2-3):171-81. PubMed ID: 10701474
[TBL] [Abstract][Full Text] [Related]
20. Once-daily venlafaxine extended release (XR) vs. fluoxetine for the treatment of depression.
Judge R
J Affect Disord; 2001 Sep; 66(1):95-8. PubMed ID: 11592259
[No Abstract] [Full Text] [Related]
[Next] [New Search]
